Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuromodulation for Prevention of Intensive Care Unit Acquired Weakness and Post Intensive Care Syndrome

NCT06238609 is registered in ClinicalTrials.gov with Bijan Najafi, PhD as lead sponsor.

NCT NCT06238609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06238609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuromodulation for Prevention of Intensive Care Unit Acquired Weakness and Post Intensive Care Syndrome
Lead sponsor
Bijan Najafi, PhD
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 28, 2023
Completion date
August 28, 2025
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood flow, muscle atrophy, muscle weakness